However, a systematic review on the efficacy of TNF inhibitors in hand osteoarthritis, administered subcutaneously rather than intra-articularly, found no significant impact on pain or grip strength over the short-term (4–6 weeks) or longer-term (12 months) periods. The gene discussed is TNF; the disease is osteoarthritis, hand.